BRIEF-Merck provides update on odanacatib development program
 

BRIEF-Merck provides update on odanacatib development program
* To discontinue development after independent adjudicatio**f major adverse cardiovascular events confirmed an increasedrisk of strokehttp://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...zw:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...zw:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/J0rsc7mN9RU